BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Isis Pharmaceuticals, Inc. 

Carlsbad Research Center
2292 Faraday Avenue
Carlsbad  California  92008-7208  U.S.A.
Phone: 760-931-9200 Fax: 760-603-4650


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology






 Company News
Genzyme Corporation (GENZ) And Isis Pharmaceuticals, Inc. (ISIS) Present KYNAMRO® Clinical Data At American Heart Association 11/19/2014 12:20:46 PM
Isis Pharmaceuticals, Inc. (ISIS) To Host Webcast To Discuss ISIS-FXI Rx Data Presented At The American Society of Hematology Annual Meeting 11/18/2014 11:43:17 AM
Cure SMA Presents Isis Pharmaceuticals, Inc. (ISIS) With SMA Breakthrough Award 11/17/2014 3:24:31 PM
Isis Pharmaceuticals, Inc. (ISIS) To Present At Upcoming Investor Conferences 11/14/2014 8:05:34 AM
AstraZeneca PLC (AZN) And Isis Pharmaceuticals, Inc. (ISIS) To Co-Develop Targeted Oligonucleotide Delivery Methods 11/13/2014 8:40:28 AM
Isis Pharmaceuticals, Inc. (ISIS) Prices Offering Of $425 Million Of 1.00% Convertible Senior Notes 11/12/2014 7:35:58 AM
Isis Pharmaceuticals, Inc. (ISIS) Announces Proposed Offering Of $425 Million of Convertible Senior Notes 11/11/2014 7:49:43 AM
Isis Pharmaceuticals, Inc. (ISIS) Reports Financial Results And Highlights For Third Quarter 2014 11/7/2014 8:38:26 AM
Isis Pharmaceuticals, Inc. (ISIS) Pockets $10 Million Milestone Payment From Biogen Idec (BIIB) 11/6/2014 6:23:17 AM
Isis Pharmaceuticals, Inc. (ISIS) Earns $5 Million In Milestone Payment From GlaxoSmithKline (GSK) For Advancement Of ISIS-GSK5 Rx 11/3/2014 6:40:03 AM
12345678910...